Related Experiment Video
Updated: Feb 27, 2026
10:35
Stereotactic Radiosurgery for Gynecologic Cancer
Published on: April 17, 2012
18.8K
Tailoring radiotherapy according to cancer subtypes
1University of Milan, European Institute of Oncology, Milan, Italy.
Breast (Edinburgh, Scotland)
|July 5, 2017
Summary
Radiotherapy improves breast cancer control, especially in high-risk patients. Tailoring treatment using tumor biology and molecular markers enhances effectiveness and survival outcomes.
Area of Science:
- Oncology
- Radiation Oncology
- Medical Physics
Background:
- Radiotherapy significantly improves locoregional control in breast cancer patients, impacting long-term survival, particularly in high-risk individuals.
- Precision in radiotherapy has advanced through optimized fractionation and techniques.
- The integration of tumor biology into adaptive radiotherapy concepts is crucial.
Purpose of the Study:
- To explore the role of biological characterization and molecular markers in refining radiotherapy strategies for breast cancer.
- To investigate how understanding breast cancer subtypes influences locoregional recurrence patterns and treatment decisions.
- To assess the potential of combining radiotherapy with targeted therapies for enhanced treatment response.
Main Methods:
- Literature review on breast cancer subtypes and their locoregional recurrence patterns.
- Analysis of molecular markers in relation to adjuvant radiotherapy efficacy.
- Exploration of combined radiotherapy and molecular targeted therapies.
Main Results:
- Luminal A breast tumors exhibit a lower risk of locoregional failure compared to HER2-positive and triple-negative subtypes.
- Molecular markers can aid in individualizing adjuvant radiotherapy decisions.
- Combining radiotherapy with targeted therapies shows potential for increased radiosensitivity and improved treatment outcomes.
Conclusions:
- Stratification based on risk categories, informed by tumor biology and molecular profiles, can optimize radiotherapy approaches.
- Personalized radiotherapy, including fractionation and technique selection, is key to improving breast cancer outcomes.
- Further evidence on molecular markers and targeted therapies will refine adjuvant radiotherapy strategies.
Related Concept Videos
02:50Combination Therapies and Personalized Medicine
6.2K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.2K
02:57Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
02:49Cancer Therapies
10.3K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.3K
01:21Cancer Survival Analysis
797
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
797
02:18Cancer
55.0K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
55.0K
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
51
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
51